Clinical Trials Directory

Trials / Completed

CompletedNCT00481260

Characteristics of Hgb C Carriers in Northern Israel and Clinical Features Among Hgb Homozygous

Status
Completed
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
HaEmek Medical Center, Israel · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Hgb C is an hemoglobinopathy quite rare in Israel. The clinical status of patients that are diagnosed as homozygous to this disease is quite benign but not study in large groups. Also the characteristics of carriers and the incidence in northern Israel were a large arab population lives, was not study. The results of this study can be useful for screening purpose in a area were another hemoglobinopathies are frequent.

Detailed description

Hgb C is an hemoglobinopathy quite rare in Israel. The clinical status of patients that are diagnosed as homozygous to this disease is quite benign but not study in large groups. Also the characteristics of carriers and the incidence in northern Israel were a large arab population lives, was not study. The results of this study can be useful for screening purpose in a area were another hemoglobinopathies are frequent. The study will record the clinical characteristics of the homozygous Hgb C patients and the hematology characteristics of all the heterozygous carriers detected in northern Israel

Conditions

Interventions

TypeNameDescription
PROCEDUREMedical history and basic laboratory analysisMedical history and basic laboratory analysis

Timeline

Start date
2007-05-01
Primary completion
2008-12-01
Completion
2008-12-01
First posted
2007-06-01
Last updated
2009-09-04

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT00481260. Inclusion in this directory is not an endorsement.